Tretiva — Research Summary
Tretiva 20 mg is a pharmaceutical-grade isotretinoin preparation manufactured by Intas Pharmaceuticals. Isotretinoin is a 13-cis-retinoic acid derivative extensively studied in dermatological research for its effects on sebaceous gland function and keratinization processes. This compound provides researchers with a standardized platform for investigating retinoid mechanisms in acne pathophysiology studies. As part of comprehensive research protocols, scientists often examine isotretinoin alongside other compounds available through specialist suppliers like Stroid UK Shop.
Laboratory Applications
Research scientists utilize isotretinoin in various investigative contexts, including sebaceous gland biology studies, comedogenesis research, and inflammatory pathway analysis. The compound’s well-characterized mechanism of action makes it valuable for comparative studies with other dermatological agents. Laboratories studying post-treatment recovery protocols often incorporate isotretinoin research within broader investigations that may include compounds from specialized therapeutic categories. Advanced research facilities frequently examine isotretinoin effects alongside studies involving selective androgen receptor modulators and peptide therapeutics to understand comprehensive treatment mechanisms.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Isotretinoin |
| Strength | 20 mg per capsule |
| Manufacturer | Intas Pharmaceuticals |
| Form | Oral capsules |
| CAS Number | 4759-48-2 |
| Molecular Formula | C₂₀H₂₈O₂ |
| Storage | Room temperature, dry |
Research Compliance
This product is intended strictly for laboratory research and in-vitro studies only. Not approved for human consumption, therapeutic use, or any clinical applications. Researchers must ensure proper laboratory protocols and safety measures when handling this compound.
